Ms. Gibson is CEO and Co-Founder of Ariel Precision Medicine, a fully vertically integrated precision medicine company providing solutions to key stakeholders across the healthcare ecosystem by integrating AI, computational biology and clinical expertise. She led the development and commercial launch of Ariel’s AI fueled ADVANCE® Platform, transforming genetic and clinical data into new insights for early diagnosis and the development of new therapeutics for complex health conditions. She served as Chief Commercial Officer of Ariel Precision Medicine until 2016, bringing over 15 years of leadership and experience in healthcare and biotech from previous roles at Purdue, Shionogi Pharmaceuticals and Gene Wiz Inc.